Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vasomotor Symptoms Associated With Menopause”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01890109
What this trial is testing

Study of Erenumab (AMG 334) in Women With Hot Flashes

Who this might be right for
Vasomotor Symptoms; Hot Flashes
Amgen 103
Not applicableStudy completedNCT04553029
What this trial is testing

A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)

Who this might be right for
Menopause
Astellas Pharma Singapore Pte. Ltd. 3,399
Not applicableStudy completedNCT07759830
What this trial is testing

A Feasibility Study of a Group Talking Therapy Programme for NHS Staff With Menopausal Hot Flushes and Night Sweats.

Who this might be right for
Vasomotor Symptoms Associated With Menopause
Queen's University, Belfast 35
Large-scale testing (Phase 3)Study completedNCT05042362
What this trial is testing

Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

Who this might be right for
Vasomotor Symptoms Associated With MenopauseHot Flashes
Bayer 396
Large-scale testing (Phase 3)Study completedNCT00421031
What this trial is testing

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vasomotor Symptoms
Wyeth is now a wholly owned subsidiary of Pfizer 540
Large-scale testing (Phase 3)Study completedNCT00683800
What this trial is testing

Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women

Who this might be right for
Vasomotor Symptoms
Pfizer 2,186
Testing effectiveness (Phase 2)Study completedNCT02834312
What this trial is testing

E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)

Who this might be right for
Hot Flushes
Donesta Bioscience 260
Large-scale testing (Phase 3)Study completedNCT00195546
What this trial is testing

Study Evaluating DVS-233 SR for Treatment of Vasomotor Symptoms Associated With Menopause

Who this might be right for
Menopause
Wyeth is now a wholly owned subsidiary of Pfizer 465
Large-scale testing (Phase 3)Study completedNCT06206421
What this trial is testing

Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Inc 277
Testing effectiveness (Phase 2)Study completedNCT03596762
What this trial is testing

BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

Who this might be right for
MenopauseHot FlashesNight Waking
Bayer 199
Not applicableStudy completedNCT07455812
What this trial is testing

A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Europe Ltd. 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT07118891
What this trial is testing

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

Who this might be right for
Vasomotor Symptoms Associated With MenopauseHealthy Volunteers
AbCellera Biologics Inc. 136
Post-approval studies (Phase 4)Study completedNCT02234362
What this trial is testing

Vortioxetine for Menopausal Depression

Who this might be right for
DepressionMenopauseVasomotor Disturbance+2 more
Massachusetts General Hospital 47
Large-scale testing (Phase 3)Study completedNCT04451226
What this trial is testing

Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 150
Not applicableLooking for participantsNCT07596069
What this trial is testing

Prevalence of Menopause-associated Symptoms Throughout the Menopausal Transition in Women Aged 40 to 70 Residing in Spain and Its Relationship With Physical Activity - MdH Study

Who this might be right for
Menopausal SymptomsPhysical Activity and Sedentary Behavior
Cuerpos Serranos S.L. 15,000
Testing effectiveness (Phase 2)Study completedNCT05034042
What this trial is testing

Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause

Who this might be right for
Hot Flashes
Astellas Pharma Inc 147
Not applicableStudy completedNCT07408115
What this trial is testing

Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women

Who this might be right for
Hot FlashesHot FlashHot Flushes, Menopause, Postmenopause+6 more
Bonafide Health 112
Post-approval studies (Phase 4)UnknownNCT01116310
What this trial is testing

Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause

Who this might be right for
Postmenopausal Women With Moderate Vasomotor Symptoms
Laboratorios Casen-Fleet S.L.U. 166
Large-scale testing (Phase 3)Study completedNCT01101841
What this trial is testing

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

Who this might be right for
Hot Flashes
Noven Therapeutics 570
Testing effectiveness (Phase 2)Study completedNCT05325775
What this trial is testing

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

Who this might be right for
Post-menopausal Vasomotor Symptoms
Acer Therapeutics Inc. 49
Next Page